Inventiva SA
PAR:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
PAR:IVA
Watchlist
Price: 2.45 EUR Market Closed
Market Cap: 212.9m EUR
Have any thoughts about
Inventiva SA?
Write Note

Intrinsic Value

IVA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IVA stock under the Base Case scenario is 5.63 EUR. Compared to the current market price of 2.45 EUR, Inventiva SA is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IVA Intrinsic Value
5.63 EUR
Undervaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Inventiva SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IVA?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Inventiva SA

Provide an overview of the primary business activities
of Inventiva SA.

What unique competitive advantages
does Inventiva SA hold over its rivals?

What risks and challenges
does Inventiva SA face in the near future?

Has there been any significant insider trading activity
in Inventiva SA recently?

Summarize the latest earnings call
of Inventiva SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inventiva SA.

Provide P/S
for Inventiva SA.

Provide P/E
for Inventiva SA.

Provide P/OCF
for Inventiva SA.

Provide P/FCFE
for Inventiva SA.

Provide P/B
for Inventiva SA.

Provide EV/S
for Inventiva SA.

Provide EV/GP
for Inventiva SA.

Provide EV/EBITDA
for Inventiva SA.

Provide EV/EBIT
for Inventiva SA.

Provide EV/OCF
for Inventiva SA.

Provide EV/FCFF
for Inventiva SA.

Provide EV/IC
for Inventiva SA.

Show me price targets
for Inventiva SA made by professional analysts.

What are the Revenue projections
for Inventiva SA?

How accurate were the past Revenue estimates
for Inventiva SA?

What are the Net Income projections
for Inventiva SA?

How accurate were the past Net Income estimates
for Inventiva SA?

What are the EPS projections
for Inventiva SA?

How accurate were the past EPS estimates
for Inventiva SA?

What are the EBIT projections
for Inventiva SA?

How accurate were the past EBIT estimates
for Inventiva SA?

Compare the revenue forecasts
for Inventiva SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inventiva SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inventiva SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inventiva SA compared to its peers.

Compare the P/E ratios
of Inventiva SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Inventiva SA with its peers.

Analyze the financial leverage
of Inventiva SA compared to its main competitors.

Show all profitability ratios
for Inventiva SA.

Provide ROE
for Inventiva SA.

Provide ROA
for Inventiva SA.

Provide ROIC
for Inventiva SA.

Provide ROCE
for Inventiva SA.

Provide Gross Margin
for Inventiva SA.

Provide Operating Margin
for Inventiva SA.

Provide Net Margin
for Inventiva SA.

Provide FCF Margin
for Inventiva SA.

Show all solvency ratios
for Inventiva SA.

Provide D/E Ratio
for Inventiva SA.

Provide D/A Ratio
for Inventiva SA.

Provide Interest Coverage Ratio
for Inventiva SA.

Provide Altman Z-Score Ratio
for Inventiva SA.

Provide Quick Ratio
for Inventiva SA.

Provide Current Ratio
for Inventiva SA.

Provide Cash Ratio
for Inventiva SA.

What is the historical Revenue growth
over the last 5 years for Inventiva SA?

What is the historical Net Income growth
over the last 5 years for Inventiva SA?

What is the current Free Cash Flow
of Inventiva SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inventiva SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inventiva SA

Current Assets 48.2m
Cash & Short-Term Investments 26.9m
Receivables 16.2m
Other Current Assets 5.1m
Non-Current Assets 21.4m
PP&E 9.1m
Intangibles 541k
Other Non-Current Assets 11.7m
Current Liabilities 50.2m
Accounts Payable 37.7m
Accrued Liabilities 3.6m
Other Current Liabilities 8.9m
Non-Current Liabilities 51.4m
Long-Term Debt 32.2m
Other Non-Current Liabilities 19.3m
Efficiency

Earnings Waterfall
Inventiva SA

Revenue
15.6m EUR
Operating Expenses
-115.6m EUR
Operating Income
-100m EUR
Other Expenses
-4.2m EUR
Net Income
-104.2m EUR

Free Cash Flow Analysis
Inventiva SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IVA Profitability Score
Profitability Due Diligence

Inventiva SA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional Revenue Growth Forecast
ROE is Increasing
33/100
Profitability
Score

Inventiva SA's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

IVA Solvency Score
Solvency Due Diligence

Inventiva SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
45/100
Solvency
Score

Inventiva SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IVA Price Targets Summary
Inventiva SA

Wall Street analysts forecast IVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IVA is 13.11 EUR with a low forecast of 6.06 EUR and a high forecast of 21 EUR.

Lowest
Price Target
6.06 EUR
147% Upside
Average
Price Target
13.11 EUR
435% Upside
Highest
Price Target
21 EUR
757% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IVA?

Click here to dive deeper.

Dividends

Inventiva SA
does not pay dividends
Shareholder Yield

Current shareholder yield for IVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IVA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Inventiva SA Logo
Inventiva SA

Country

France

Industry

Biotechnology

Market Cap

212m EUR

Dividend Yield

0%

Description

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. The company is headquartered in Daix, Occitanie and currently employs 100 full-time employees. The company went IPO on 2017-02-15. The firm focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.

Contact

OCCITANIE
Daix
50 rue de Dijon, Daix
+33380447500.0
inventivapharma.com

IPO

2017-02-15

Employees

100

Officers

Co-Founder, CEO & Chairman
Mr. Frederic Cren
Co-Founder, Chief Scientific Officer, Deputy CEO & Director
Dr. Pierre Broqua Ph.D.
Deputy GM & CFO
Mr. Jean Volatier
Chief Operating Officer
Ms. Alice Roudot-Ketelers Pharm.D.
General Counsel
Mr. Eric Duranson L.L.M.
Head of Human Resources
Ms. Nathalie Harroy
Show More
Executive VP and Business Development & Alliance Management
Dr. Kristina Meyer Ph.D.
Chief Medical Officer
Dr. Michael Cooreman
Executive Vice President of Strategy & Corporate Affairs
Ms. Pascaline Clerc Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one IVA stock?

The intrinsic value of one IVA stock under the Base Case scenario is 5.63 EUR.

Is IVA stock undervalued or overvalued?

Compared to the current market price of 2.45 EUR, Inventiva SA is Undervalued by 56%.

Back to Top